CannMed Coffee Talk

This episode's guest is Keith Allen, Director of Bioinformatics at Front Range Biosciences. Keith is tasked with exploring the cannabis genome to find genetic markers that can be selected in breeding projects. His current focus is on cannabinoid and terpene production, but as we discuss in our conversation, there are a number of different traits cannabis and hemp breeders will want to select for in the future, including yield, drought resistance, pathogen resistance, flowering time, heartiness for the outdoor environment, and more. The opportunity for improving the cannabis plant is only restricted by our understanding of the genome, which Keith readily admits, is still in its infancy. 

Keith will be presenting on “Gene Families and Gene Networks Underlying Oil Production in Cannabis Trichomes” at CannMed 2021 this Spring. So please do consider picking up your ticket for the event now. 

Click the player below to listen, and thanks to our sponsor, The Growers Network.

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources

Front Range Biosciences WebsiteGenomic characterization of the complete terpene synthase gene family from Cannabis sativa

On this episode, we talk with CannMed 2020 presenter Eloise Theisen of Radicle Health. Eloise is a board-certified Adult Geriatric Nurse Practitioner with over 20 years experience in nursing. She started her own cannabis practice about 6 years ago and she has treated over 6000 patients using cannabis. There are very few healthcare providers nationally with the same level of expertise and experience. Eloise is the President of the American Cannabis Nurses Association and will serve as President through 2022.

Eloise made her first CannMed appearance at our 2019 event in a presentation sharing her experience using Cannabis to treat geriatric patients. We talked about some of the unique challenges that come with working with seniors including the stigma older patients have towards cannabis, how the endocannabinoid system changes as we age, and navigating drug interactions. 

We are excited to have Eloise as a presenter at CannMed 2020 this year, but that will not be her only contribution to the event. Eloise will also be an instructor at a full-day Medical Practicum along with Dr. Bonni Goldstein, Dr. Dustin Sulak, Dr. Kevin Spelman. This is a great opportunity for healthcare professionals to learn about the latest research into cannabinoid therapies and also tap into the deep clinical experience the instructors have to offer. When you consider that most medical schools don’t teach the endocannabinoid system, courses like this are really the only way healthcare providers can learn how to properly administer cannabinoid therapies. Attendees will walk away with practical information about the different types of extractions and products that are on the market and optimal dosing. 

Due to federal guidelines, CME credits for physicians are not available for the practicum, However, This course is approved by the California Board of Registered Nursing for 9.5 contact hours**

Learn more at CannMedEvents.com/practicum. 

Click the player below to listen, and thanks to our sponsor, Radicle Health

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Radicle Health Website American Cannabis Nurses Association WebsiteUsing Cannabis to Treat Chronic Pain in the Geriatric Population (CannMed 2019 Presentation)

On this episode, we talk with CannMed 2020 presenter Eloise Theisen of Radicle Health. Eloise is a board-certified Adult Geriatric Nurse Practitioner with over 20 years experience in nursing. She started her own cannabis practice about 6 years ago and she has treated over 6000 patients using cannabis. There are very few healthcare providers nationally with the same level of expertise and experience. Eloise is the President of the American Cannabis Nurses Association and will serve as President through 2022.

Eloise made her first CannMed appearance at our 2019 event in a presentation sharing her experience using Cannabis to treat geriatric patients. We talked about some of the unique challenges that come with working with seniors including the stigma older patients have towards cannabis, how the endocannabinoid system changes as we age, and navigating drug interactions. 

We are excited to have Eloise as a presenter at CannMed 2020 this year, but that will not be her only contribution to the event. Eloise will also be an instructor at a full-day Medical Practicum along with Dr. Bonni Goldstein, Dr. Dustin Sulak, Dr. Kevin Spelman. This is a great opportunity for healthcare professionals to learn about the latest research into cannabinoid therapies and also tap into the deep clinical experience the instructors have to offer. When you consider that most medical schools don’t teach the endocannabinoid system, courses like this are really the only way healthcare providers can learn how to properly administer cannabinoid therapies. Attendees will walk away with practical information about the different types of extractions and products that are on the market and optimal dosing. 

Due to federal guidelines, CME credits for physicians are not available for the practicum, However, This course is approved by the California Board of Registered Nursing for 9.5 contact hours**

Learn more at CannMedEvents.com/practicum. 

Click the player below to listen, and thanks to our sponsor, Radicle Health

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Radicle Health Website American Cannabis Nurses Association WebsiteUsing Cannabis to Treat Chronic Pain in the Geriatric Population (CannMed 2019 Presentation)

On the latest episode of CannMed Coffee Talk, we welcome Brianna Cassidy, Chief Science Officer of CDX Analytics.

Brianna and the team at CDX perform safety testing on all types of cannabis samples, including potency, pesticides, heavy metals, residual solvents, and microbial contamination. As you will hear in the podcast, Brianna takes a creative and analytical approach to solving problems that come with testing cannabis products. At CannMed 2020, Brianna will share her process for evaluating new analytical methods and technologies for her lab. As you can imagine, there are a number of vendors looking to install their systems in cannabis testing labs, so it helps to have a thorough and objective process to choose the best option. 

Our team knows first hand that Brianna is thorough when evaluating new technologies. She and the team at CDX provided data that is an important part of the Medicinal Genomics Manufacturer Validation Document. 

Brianna and I also discussed the issue of consistency when it comes to potency testing. I was surprised to learn that Cannabis flowers from the same batch are often 50% more or less potent than what's reported on the package. She also explained how water content can make a big difference in potency results. 

If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. But hopefully, by the end of this episode, you will have a much better appreciation for cannabis testing labs!

Click the player below to listen, and thanks to our sponsor, The Cannabis Scientist

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Cannabis UncertaintyCDX Analytics website

On the latest episode of CannMed Coffee Talk, we welcome Brianna Cassidy, Chief Science Officer of CDX Analytics.

Brianna and the team at CDX perform safety testing on all types of cannabis samples, including potency, pesticides, heavy metals, residual solvents, and microbial contamination. As you will hear in the podcast, Brianna takes a creative and analytical approach to solving problems that come with testing cannabis products. At CannMed 2020, Brianna will share her process for evaluating new analytical methods and technologies for her lab. As you can imagine, there are a number of vendors looking to install their systems in cannabis testing labs, so it helps to have a thorough and objective process to choose the best option. 

Our team knows first hand that Brianna is thorough when evaluating new technologies. She and the team at CDX provided data that is an important part of the Medicinal Genomics Manufacturer Validation Document. 

Brianna and I also discussed the issue of consistency when it comes to potency testing. I was surprised to learn that Cannabis flowers from the same batch are often 50% more or less potent than what's reported on the package. She also explained how water content can make a big difference in potency results. 

If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. But hopefully, by the end of this episode, you will have a much better appreciation for cannabis testing labs!

Click the player below to listen, and thanks to our sponsor, The Cannabis Scientist

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Cannabis UncertaintyCDX Analytics website

We are excited to announce CannMed 2020’s Keynote Presenter in the Cultivation Focus Area, and our guest on the latest Coffee Talk Podcast, is Seth Crawford, PhD.

Dr. Crawford is the owner and co-founder of Oregon CBD, along with his brother, Eric. Together (and with the help of some 41 scientists, geneticists and breeders) they specialize in turning out new, exciting and unique strains of industrial hemp varieties designed for maximum yield in large-scale production. Their early adoption of disruptive testing technology allowed Oregon CBD to produce a number of industry firsts—the first high cannabinoid content auto-flowering CBD plant, and the first pure CBG,CBC, CBDV, CBGV and CBCV field-ready varieties. Their growing library is now full of novel phenotype, chemotypes and genotypes and they lead the country in the production and purity of feminized seed.

Even though he’s been growing cannabis since 2003 and hemp since 2015, Dr. Crawford also found time to earn advanced degrees from Oregon State University (MPP, public policy) and the University of Oregon (MS, Ph.D., sociology) and enjoyed a decade-long teaching career at OSU. His published work on the political economy of cannabis provided the first structural analysis of Oregon’s decentralized, pre-legalization production and distribution networks. In 2015, he grew his hobby-level breeding operation into industrial-scale field production of novel, non-psychoactive cannabis. 

His company’s most recent invention is 100:1 CBD to THC ratio varieties. And their ultimate goal is to develop a library of unique varieties that will allow farmers to succeed in any environment and produce any cannabinoid. In addition to their private projects, Dr. Crawford’s Oregon CBD is engaged in public research programs on feminized seed, flowering sensitivity, ratio inheritance, and non-destructive testing.

Needless to say, we delighted to have Seth Crawford with us on our Coffee Talk Podcast, and heading up the vitally important Cultivation Focus Area at CannMed 2020.

Additional Resources

CannMed 2018 Presentation - Breeding Distinct Industrial Hemp Varieties for the 21st CenturyOregonCBD websiteOregonCBD Farmer's Resources

We are excited to announce CannMed 2020’s Keynote Presenter in the Cultivation Focus Area, and our guest on the latest Coffee Talk Podcast, is Seth Crawford, PhD.

Dr. Crawford is the owner and co-founder of Oregon CBD, along with his brother, Eric. Together (and with the help of some 41 scientists, geneticists and breeders) they specialize in turning out new, exciting and unique strains of industrial hemp varieties designed for maximum yield in large-scale production. Their early adoption of disruptive testing technology allowed Oregon CBD to produce a number of industry firsts—the first high cannabinoid content auto-flowering CBD plant, and the first pure CBG,CBC, CBDV, CBGV and CBCV field-ready varieties. Their growing library is now full of novel phenotype, chemotypes and genotypes and they lead the country in the production and purity of feminized seed.

Even though he’s been growing cannabis since 2003 and hemp since 2015, Dr. Crawford also found time to earn advanced degrees from Oregon State University (MPP, public policy) and the University of Oregon (MS, Ph.D., sociology) and enjoyed a decade-long teaching career at OSU. His published work on the political economy of cannabis provided the first structural analysis of Oregon’s decentralized, pre-legalization production and distribution networks. In 2015, he grew his hobby-level breeding operation into industrial-scale field production of novel, non-psychoactive cannabis. 

His company’s most recent invention is 100:1 CBD to THC ratio varieties. And their ultimate goal is to develop a library of unique varieties that will allow farmers to succeed in any environment and produce any cannabinoid. In addition to their private projects, Dr. Crawford’s Oregon CBD is engaged in public research programs on feminized seed, flowering sensitivity, ratio inheritance, and non-destructive testing.

Needless to say, we delighted to have Seth Crawford with us on our Coffee Talk Podcast, and heading up the vitally important Cultivation Focus Area at CannMed 2020.

Additional Resources

CannMed 2018 Presentation - Breeding Distinct Industrial Hemp Varieties for the 21st CenturyOregonCBD websiteOregonCBD Farmer's Resources

In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California.

If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. The cannabis testing labs are sort of like unsung heroes in the cannabis industry. They serve a very important role in ensuring consumer and patient safety, but they rarely get recognized for it.

During the conversation, Ini discussed the types of tests labs perform in California, what challenges they face being in a regulated market, and how they balance keeping customers happy while also keeping consumers safe. So by the end of this episode, you will likely have a much better appreciation for cannabis testing labs! Ini also describes the research he has performed on analyzing the ingredients in vaporizer cartridges, in the wake of last year’s vaping crisis. 

Click the player below to listen, and thanks to our sponsor, CannaSafe Labs!

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Vapes: What Are You Actually Inhaling?CannMed 2019 Panel - The Future of Cannabis Testing

In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California.

If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. The cannabis testing labs are sort of like unsung heroes in the cannabis industry. They serve a very important role in ensuring consumer and patient safety, but they rarely get recognized for it.

During the conversation, Ini discussed the types of tests labs perform in California, what challenges they face being in a regulated market, and how they balance keeping customers happy while also keeping consumers safe. So by the end of this episode, you will likely have a much better appreciation for cannabis testing labs! Ini also describes the research he has performed on analyzing the ingredients in vaporizer cartridges, in the wake of last year’s vaping crisis. 

Click the player below to listen, and thanks to our sponsor, CannaSafe Labs!

SIGN UP FOR PODCAST UPDATES AND ENTER TO WIN 2 VIP DINNER TICKETS!

Additional Resources:

Vapes: What Are You Actually Inhaling?CannMed 2019 Panel - The Future of Cannabis Testing

We are excited to announce Bonni S. Goldstein, MD as the CannMed 2020’s Keynote Presenter in the Medicine Focus Area.

The title of Dr. Goldstein’s presentation is “Cannabis Medicine for Children.” She will be sharing her latest clinical findings, including promising results from her clinical practice focusing on the use of phytocannabinoid medicines to treat serious pediatric medical condition, including epilepsy, autism, and cancer.

You can hear Dr. Goldstein talk about her work on the latest episode of the CannMed Coffee Talk Podcast where she joins us as our guest. (Use the player at the bottom at the post to listen.)

As one of the most respected and experienced medical practitioners in this field, we are honored to have Dr. Goldstein once again take a major role at CannMed 2020. She has been a member of CannMed’s Advisory Board for three years and developed the CannMed Medical Practicum, a day-long workshop where healthcare providers, clinicians, caregivers, and patients learn the science of medical cannabis as well as practical advice about how to use various cannabinoids to treat a range of medical conditions.

A native of New Jersey, Dr. Goldstein received her undergraduate degree at Rutgers University, and her medical degree at Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey. She did her internship, residency, and chief residency at Children’s Hospital Los Angeles (CHLA). Dr. Goldstein was a Clinical Instructor in Pediatrics at USC School of Medicine, Emergency Transport Attending Physician at CHLA, and Emergency Medicine Attending Physician in the Pediatric Emergency Department at LA County - USC Medical Center.

Her interest in the science of medicinal cannabis was kindled more than ten years ago after witnessing its beneficial effects in a friend who was seriously ill. Since then, she has been evaluating and treating both adult and pediatric patients for the use of medicinal cannabis.

Dr. Goldstein is a sought-after lecturer to many patient support programs, including the Cancer Support Community in Southern California. She has been a featured speaker at CannMed since our first conference at Harvard University in 2016.  She has also presented at the Medical Cannabis for Autism conference at Children’s Hospital of Philadelphia and the International Congress on Clinical Trials in Cannabis in London, as well as many other cannabis conferences.

She is currently the Medical Director of Canna-Centers, a Los Angeles-based medical practice devoted to helping patients use cannabis medicine for serious and chronic medical conditions. She is also Medical Advisor to WeedMaps.com, a board member of the International Association of Cannabis as Medicine, and a member of the International Cannabinoid Research Society and the Society of Cannabis Clinicians.  She is the author of Cannabis Revealed and her second book, Cannabis is Medicine, will be published by Little, Brown Spark in September 2020.

We are thrilled to have Dr. Goldstein as one of our Keynote Speakers and look forward to her participation in the CannMed Medical Practicum!

Additional Resources:

Canna-Centers WebsiteWPA4AProject CBD Dr. Goldstein's CannMed Presentations - 2018 | 2017